Dataset from A Phase IIIb, Randomized, Double-Blind, Multi-Center, Placebo- Controlled, Dose-Optimization, Cross-Over, Analog Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention-Deficit/Hyperactivity Disorder
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006848
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this study is to assess the time of onset of Vyvanse compared to
placebo, in the analog classroom as measured by the Swanson, Kotkin, Agler, M. Flynn and
Pelham (SKAMP) deportment scale in children (aged 6-12) diagnosed with
Attention-Deficit/Hyperactivity Disorder (ADHD).
创建时间：
2024-11-26
